The DIabetic REtinopathy Candesartan Trials (DIRECT) Programme: Baseline characteristics

Anne Katrin Sjølie, Rudy Bilous, Nish Chaturvedi, John Fuller, Ywonne Fox, Michael George, Ronald Klein, Trevor Orchard, Hans Henrik Parving, Massimo Porta, Anders Svensson, Ingrid Warnold, Graham Price, Steven Aldington, Aaron Deveney, Joanne Holloway, Robert Janiak, Dermot Kenny, Eva Krisin, Helen LipinskiNicole Otterbeck, Pia Strannelind, Therese Tillin, Lars Wilhelmsen, Alan Bird, Hans Wedel, Carl David Agardh, Francois Bonnici, Bernard Charbonnel, Mark Cooper, Ivan Dedov, Robert Gardiner, Ramon Gomis, Hasan Ilkova, Nicholas Katsilambros, Zsuzsa Kerenyi, Stephan Martin, Pascale Massin, Valdis Pirags, Itamar Raz, Guntram Schernthaner, Marina Shestakova, Krzysztof Strojek, Margareta Puu

Research output: Contribution to journalArticle

44 Citations (Scopus)

Fingerprint Dive into the research topics of 'The DIabetic REtinopathy Candesartan Trials (DIRECT) Programme: Baseline characteristics'. Together they form a unique fingerprint.

Medicine & Life Sciences